Highlights
NASDAQ: IMGN       Immunogen Inc
Last Price Today's Change   Day's Range   Trading Volume
3.215   -0.005 (0.16%)  3.07 - 3.25  1,224,101

Overview

 
Avg Volume (4 weeks):1,632,345
4 Weeks Range:2.36 - 3.76
4 Weeks Price Volatility (%):
61.07%
52 Weeks Range:1.76 - 6.13
52 Weeks Price Volatility (%):
33.30%
Average Price Target: 15.00
Price Target Upside/Downside: +11.785

Headlines



No recent Headlines for this stock.


Business Background

Immunogen Inc is a clinical-stage biotechnology company from the United States. Its focus is antibody-drug conjugate, or ADC, technology, which uses an antibody that fixes on a target (its antigen) found on tumor cells to deliver a specific cancer-killing agent. The technology is used in Kadcyla (ado-trastuzumab emtansine)--a registered trademark of Genentech, a member of the Roche Group--to kill solid tumors. Companies such as Amgen, Genentech/Roche, Lilly, Novartis, Sanofi, and Takeda have licensed limited rights to use the ADC technology in their therapies.

  Be the first to like this.
 


 

2836  2761  462  2911 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CHK 0.70+0.03 
 FCEL 0.827+0.282 
 AMD 37.36+0.65 
 AABA 19.630.00 
 ET 11.03-0.63 
 GE 11.255-0.165 
 DIS 145.194+6.614 
 BAC 32.72-0.37 
 I 15.22-5.17 
 CLVS 6.255+0.79 
Partners & Brokers